Pulmatrix Days Of Payables Outstanding from 2010 to 2024

PULM Stock  USD 6.64  0.70  9.54%   
Pulmatrix Days Of Payables Outstanding yearly trend continues to be very stable with very little volatility. Days Of Payables Outstanding is likely to grow to 49.45 this year. During the period from 2010 to 2024, Pulmatrix Days Of Payables Outstanding quarterly data regression pattern had sample variance of  4,122 and median of  49.45. View All Fundamentals
 
Days Of Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
45.04285346
Current Value
49.45
Quarterly Volatility
64.19931569
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pulmatrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmatrix's main balance sheet or income statement drivers, such as Interest Expense of 185.2 K, Other Operating Expenses of 16.9 M or Research Development of 10.3 M, as well as many indicators such as Price To Sales Ratio of 0.88, Dividend Yield of 0.1 or PTB Ratio of 0.4. Pulmatrix financial statements analysis is a perfect complement when working with Pulmatrix Valuation or Volatility modules.
  
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Latest Pulmatrix's Days Of Payables Outstanding Growth Pattern

Below is the plot of the Days Of Payables Outstanding of Pulmatrix over the last few years. It is Pulmatrix's Days Of Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulmatrix's overall financial position and show how it may be relating to other accounts over time.
Days Of Payables Outstanding10 Years Trend
Pretty Stable
   Days Of Payables Outstanding   
       Timeline  

Pulmatrix Days Of Payables Outstanding Regression Statistics

Arithmetic Mean56.04
Geometric Mean41.36
Coefficient Of Variation114.56
Mean Deviation29.95
Median49.45
Standard Deviation64.20
Sample Variance4,122
Range264
R-Value0.18
Mean Square Error4,302
R-Squared0.03
Significance0.53
Slope2.52
Total Sum of Squares57,702

Pulmatrix Days Of Payables Outstanding History

2024 49.45
2023 45.04
2022 280.66
2020 19.91
2019 17.05
2018 33.3
2017 16.28

About Pulmatrix Financial Statements

Pulmatrix investors utilize fundamental indicators, such as Days Of Payables Outstanding, to predict how Pulmatrix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Of Payables Outstanding 45.04  49.45 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.64)
Revenue Per Share
3.119
Quarterly Revenue Growth
(0.16)
Return On Assets
(0.30)
Return On Equity
(0.59)
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.